Robert Walsh - 16 Jun 2023 Form 3 Insider Report for BIOCEPT INC

Role
VP, Controller
Signature
/w/ Robert Walsh
Issuer symbol
N/A
Transactions as of
16 Jun 2023
Net transactions value
$0
Form type
3
Filing time
20 Jun 2023, 19:09:58 UTC
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding BIOC Employee Stock option (right to buy) 16 Jun 2023 Common Stock 806 $30.90 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares subject to the option shall vest on the first anniversary of May 23, 2022 with the balance vesting in equal monthly installments until fully vested on May 23, 2026.